
Lamepro
About Lamepro
Lamepro is a Healthcare company based in Netherlands, and was acquired by PharmaNovia in March 2022. Pharmaceutical products for multiple disease treatments are provided. Its focus areas include Diversified Pharmaceuticals.
Company details
Pharmaceutical products targeted at treatments for various diseases are distributed by Lamepro, operating within the healthcare sector in the Netherlands. Focus is placed on supplying medications to support medical practices across multiple therapeutic categories. Activities encompass procurement, storage, and delivery of pharmaceuticals, with emphasis on regulatory compliance in the European market. The companys domain, lamepro.nl, facilitates online access to its catalog and services.
- Headquarters Netherlands
- Stage Acquired
- SectorsHealthcare
- Website lamepro.nl
- Acquired by PharmaNovia (Mar 2022)
- Investors
- Acquired byPharmaNovia
(Mar 2022)
Investors in Lamepro
Lamepro has secured backing from 1 investor. Prominent investors backing the company include PharmaNovia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic oncology products and antibiotics are manufactured in Copenhagen. | 2003 | pharmanovia.com | Copenhagen, Denmark |
Investor details for Lamepro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lamepro
Complete news archive for Lamepro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lamepro
Lamepro is headquartered in Netherlands.
Pharmaceutical products targeted at treatments for various diseases are distributed by Lamepro, operating within the healthcare sector in the Netherlands. Focus is placed on supplying medications to support medical practices across multiple therapeutic categories. Activities encompass procurement, storage, and delivery of pharmaceuticals, with emphasis on regulatory compliance in the European market. The companys domain, lamepro.nl, facilitates online access to its catalog and services.
Lamepro has 1 investor. Key investors include PharmaNovia.
Yes. Lamepro was acquired by PharmaNovia in March 2022.
